Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Charcot Disease”

1,148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,148 results

Not applicableLooking for participantsNCT06595212
What this trial is testing

Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach

Who this might be right for
ALSFTD
Azienda Ospedaliero-Universitaria di Modena 45
Early research (Phase 1)Study completedNCT02870634
What this trial is testing

Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Collaborative Medicinal Development Pty Limited 50
Testing effectiveness (Phase 2)Ended earlyNCT03580616
What this trial is testing

Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Elijah W. Stommel 43
Not applicableLooking for participantsNCT07044804
What this trial is testing

Non-Invasive Brain Stimulation to Improve Language in Down Syndrome.

Who this might be right for
Down Syndrome
Floriana Costanzo 36
Early research (Phase 1)Looking for participantsNCT06671236
What this trial is testing

Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Novabio Therapeutics 12
Not applicableStudy completedNCT02670226
What this trial is testing

Muscular Biomarkers in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Tours 37
Not applicableStudy completedNCT02104921
What this trial is testing

Innovative Ultrasound Technology in Neuromuscular Disease

Who this might be right for
Amyotrophic Lateral SclerosisMuscular DystrophyRadiculopathy+4 more
Beth Israel Deaconess Medical Center 223
Not applicableStudy completedNCT01592552
What this trial is testing

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Who this might be right for
Alzheimer's DiseaseMultiple SclerosisParkinson's Disease+2 more
Sanguine Biosciences 20
Early research (Phase 1)UnknownNCT02881489
What this trial is testing

Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Warmia and Mazury 30
Large-scale testing (Phase 3)Study completedNCT05136885
What this trial is testing

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Large-scale testing (Phase 3)Ended earlyNCT04248465
What this trial is testing

An Efficacy and Safety Study of Ravulizumab in ALS Participants

Who this might be right for
Amyotrophic Lateral SclerosisALS
Alexion Pharmaceuticals, Inc. 382
Testing effectiveness (Phase 2)Study completedNCT04098406
What this trial is testing

Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Clene Nanomedicine 45
Testing effectiveness (Phase 2)Study completedNCT00326625
What this trial is testing

Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Teva Pharmaceutical Industries, Ltd. 366
Not applicableStudy completedNCT02982343
What this trial is testing

BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease

Who this might be right for
Charcot-Marie-Tooth Disease, Type IA
University College London Hospitals 16
Not applicableStudy completedNCT03645031
What this trial is testing

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Neuromuscular Diseases
University of Florida 29
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Not applicableStudy completedNCT00149045
What this trial is testing

Follow up and Observation of Charcot Marie Tooth Disease in Families

Who this might be right for
Charcot-Marie-Tooth Disease
Hadassah Medical Organization
Not applicableLooking for participantsNCT06578195
What this trial is testing

ASSESS ALL ALS Study

Who this might be right for
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix 2,000
Not applicableStudy completedNCT05407428
What this trial is testing

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
NeuraLight 45
Load More Results